This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Altria's (MO) Q4 Earnings Coming Up: Factors Worth Noting
by Zacks Equity Research
Altria's (MO) fourth-quarter results are likely to reflect cigarette volume concerns, though strength in pricing and RRPs is likely to have been an upside.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The Estee Lauder Companies (EL) Emerging Market Presence Strong
by Zacks Equity Research
The Estee Lauder Companies (EL) is benefiting from continued momentum in several emerging markets globally. Strong online business is a major driver.
The Estee Lauder Companies (EL) Hurt by Softness in Asia Region
by Zacks Equity Research
The Estee Lauder Companies (EL) is bearing the brunt of weakness in Asia travel retail. Thanks to its solid international presence, it remains exposed to unfavorable currency rates.
Coty (COTY) Up 15.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zoom Video Communications and Estee Lauder have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Zoom Video Communications and Estee Lauder have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Estee Lauder (EL)
by Andrew Rocco
Estee Lauder faces significant challenges as it navigates a landscape marked by international economic uncertainties, a stretched valuation, and fierce competition.
Why Is Estee Lauder (EL) Up 11.6% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Estee Lauder (EL) Lowers FY24 View Despite Q1 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) first-quarter fiscal 2024 results reflect lower net sales and earnings. Management lowered the fiscal 2024 view on incremental external headwinds.
Estee Lauder (EL) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Estee Lauder (EL) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
What Awaits The Estee Lauder Companies (EL) in Q1 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) first-quarter performance will likely reflect economic hurdles in China, volatile inflation levels and foreign currency fluctuations.
Earnings Preview: Estee Lauder (EL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Estee Lauder Companies (EL) Hurt by Cost & Currency Woes
by Zacks Equity Research
The Estee Lauder Companies (EL) is operating amid volatile inflation levels. The company's solid international presence keeps it exposed to unfavorable currency fluctuations.
Amazon and The Estee Lauder have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Amazon and The Estee Lauder are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: The Estee Lauder Companies (EL)
by Derek Lewis
Estee Lauder shares have faced selling pressure following quarterly releases in 2023, underperforming relative to the general market in a big way. Can shares turnaround?
Here's Why The Estee Lauder Companies (EL) Dropped 42.6% YTD
by Zacks Equity Research
The Estee Lauder Companies (EL) is cautious about economic hurdles in China, volatile inflation levels, foreign currency fluctuations and concerns surrounding recession.
Implied Volatility Surging for Estee Lauder (EL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Estee Lauder (EL) stock based on the movements in the options market lately.
The Estee Lauder Companies (EL) Dulls on Cost & Currency Woes
by Zacks Equity Research
The Estee Lauder Companies (EL) is battling volatile inflation levels. The company's international presence exposes it to risks of unfavorable currency rates.
The Estee Lauder Companies (EL) Dips More Than 35%: Here's Why
by Zacks Equity Research
The Estee Lauder Companies (EL) is cautious about economic hurdles in China, volatile inflation levels, foreign currency fluctuations and concerns surrounding the recession.
Estee Lauder (EL) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Estee Lauder's (EL) fourth-quarter fiscal 2023 results reflect strength in nearly all categories other than Skin Care. The company remains well-placed for fiscal 2024.
Pre-Markets in Red to Close a Disappointing Week
by Zacks Equity Research
Pre-Markets in Red to Close a Disappointing Week.
Deep-Red Start to Close Worst Trading Week in Months
by Mark Vickery
Month to date, the Dow is -3.75%, the S&P -5.55%, the Nasdaq -7.59% and the small-cap Russell 2000 -8.46%.
Compared to Estimates, Estee Lauder (EL) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Estee Lauder (EL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Estee Lauder (EL) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 275% and 3.72%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From The Estee Lauder Companies (EL) Q4 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) fourth-quarter results are likely to reflect the impacts of soft recovery in Asia travel retail. However, prudent pricing and enhanced product distribution bode well.